Article
The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A…
Blood and Lymphatic Cancer: Targets and Therapy · 2024 · Almodovar Diaz AA, Alouch SS, Chawla Y, Gonsalves WI
Key facts
| Title | The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review |
|---|---|
| First author | Almodovar Diaz AA, Alouch SS, Chawla Y, Gonsalves WI |
| Journal | Blood and Lymphatic Cancer: Targets and Therapy |
| Published | Dec 6, 2024 |
| DOI | 10.2147/BLCTT.S490021 |
| Devices mentioned | 089193, 201823 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1